These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
281 related articles for article (PubMed ID: 22133795)
1. Analysis of outcomes for intravitreal bevacizumab in the treatment of choroidal neovascularization secondary to ocular histoplasmosis. Cionni DA; Lewis SA; Petersen MR; Foster RE; Riemann CD; Sisk RA; Hutchins RK; Miller DM Ophthalmology; 2012 Feb; 119(2):327-32. PubMed ID: 22133795 [TBL] [Abstract][Full Text] [Related]
2. Verteporfin photodynamic therapy combined with intravitreal bevacizumab for neovascular age-related macular degeneration. Kaiser PK; ; Boyer DS; Garcia R; Hao Y; Hughes MS; Jabbour NM; Kaiser PK; Mieler W; Slakter JS; Samuel M; Tolentino MJ; Roth D; Sheidow T; Strong HA Ophthalmology; 2009 Apr; 116(4):747-55, 755.e1. PubMed ID: 19243834 [TBL] [Abstract][Full Text] [Related]
3. Verteporfin therapy and intravitreal bevacizumab combined and alone in choroidal neovascularization due to age-related macular degeneration. Lazic R; Gabric N Ophthalmology; 2007 Jun; 114(6):1179-85. PubMed ID: 17544776 [TBL] [Abstract][Full Text] [Related]
4. Intravitreal injection of bevacizumab combined with verteporfin photodynamic therapy for choroidal neovascularization in age-related macular degeneration. Smith BT; Dhalla MS; Shah GK; Blinder KJ; Ryan EH; Mittra RA Retina; 2008 May; 28(5):675-81. PubMed ID: 18463509 [TBL] [Abstract][Full Text] [Related]
5. Intravitreal anti-vascular endothelial growth factor therapy versus photodynamic therapy for idiopathic choroidal neovascularization. Kang HM; Koh HJ Am J Ophthalmol; 2013 Apr; 155(4):713-9, 719.e1. PubMed ID: 23219069 [TBL] [Abstract][Full Text] [Related]
6. Combined photodynamic therapy with verteporfin and intravitreal bevacizumab for choroidal neovascularization in age-related macular degeneration. Dhalla MS; Shah GK; Blinder KJ; Ryan EH; Mittra RA; Tewari A Retina; 2006; 26(9):988-93. PubMed ID: 17151484 [TBL] [Abstract][Full Text] [Related]
8. Photodynamic therapy with or without intravitreal bevacizumab for polypoidal choroidal vasculopathy: two years of follow-up. Lee YA; Yang CH; Yang CM; Ho TC; Lin CP; Huang JS; Chen MS Am J Ophthalmol; 2012 Nov; 154(5):872-880.e2. PubMed ID: 22831838 [TBL] [Abstract][Full Text] [Related]
9. Anti-vascular endothelial growth factor monotherapy versus combination treatment with photodynamic therapy for subfoveal choroidal neovascularization secondary to causes other than age-related macular degeneration. Chen L; Miller JW; Vavvas D; Kim IK Retina; 2011 Nov; 31(10):2078-83. PubMed ID: 21691258 [TBL] [Abstract][Full Text] [Related]
10. Intravitreal bevacizumab (Avastin) in combination with verteporfin photodynamic therapy for choroidal neovascularization associated with age-related macular degeneration (IBeVe Study). Costa RA; Jorge R; Calucci D; Melo LA; Cardillo JA; Scott IU Graefes Arch Clin Exp Ophthalmol; 2007 Sep; 245(9):1273-80. PubMed ID: 17333238 [TBL] [Abstract][Full Text] [Related]
11. Intravitreal bevacizumab for choroidal neovascularization in ocular histoplasmosis. Schadlu R; Blinder KJ; Shah GK; Holekamp NM; Thomas MA; Grand MG; Engelbrecht NE; Apte RS; Joseph DP; Prasad AG; Smith BT; Sheybani A Am J Ophthalmol; 2008 May; 145(5):875-8. PubMed ID: 18321466 [TBL] [Abstract][Full Text] [Related]
12. Bevacizumab vs photodynamic therapy for choroidal neovascularization in multifocal choroiditis. Parodi MB; Iacono P; Kontadakis DS; Zucchiatti I; Cascavilla ML; Bandello F Arch Ophthalmol; 2010 Sep; 128(9):1100-3. PubMed ID: 20837791 [TBL] [Abstract][Full Text] [Related]
13. Intravitreal anti-VEGF versus photodynamic therapy with verteporfin for treatment of myopic choroidal neovascularization. Yoon JU; Byun YJ; Koh HJ Retina; 2010 Mar; 30(3):418-24. PubMed ID: 20094012 [TBL] [Abstract][Full Text] [Related]
14. Laser photocoagulation, photodynamic therapy, and intravitreal bevacizumab for the treatment of juxtafoveal choroidal neovascularization secondary to pathologic myopia. Parodi MB; Iacono P; Papayannis A; Sheth S; Bandello F Arch Ophthalmol; 2010 Apr; 128(4):437-42. PubMed ID: 20142520 [TBL] [Abstract][Full Text] [Related]
15. Combined photodynamic therapy with intravitreal bevacizumab injections for polypoidal choroidal vasculopathy: long-term visual outcome. Kang HM; Koh HJ; Lee CS; Lee SC Am J Ophthalmol; 2014 Mar; 157(3):598-606.e1. PubMed ID: 24269378 [TBL] [Abstract][Full Text] [Related]
16. Combined intravitreal anti-VEGF and verteporfin photodynamic therapy for juxtafoveal and extrafoveal choroidal neovascularization as an alternative to laser photocoagulation. Han DP; McAllister JT; Weinberg DV; Kim JE; Wirostko WJ Eye (Lond); 2010 Apr; 24(4):713-6. PubMed ID: 19498454 [TBL] [Abstract][Full Text] [Related]
17. INTRAVITREAL ANTIVASCULAR ENDOTHELIAL GROWTH FACTOR FOR THE TREATMENT OF CHOROIDAL NEOVASCULARIZATION SECONDARY TO OCULAR HISTOPLASMOSIS: Ten-Year Follow-Up. Dudenhoefer NE; Noble CW; Petersen MR; Foster RE; Riemann CD; Sisk RA; Hutchins RK; Miller DM Retina; 2022 Aug; 42(8):1568-1573. PubMed ID: 35877968 [TBL] [Abstract][Full Text] [Related]
18. Prospective comparison of low-fluence photodynamic therapy combined with intravitreal bevacizumab versus bevacizumab monotherapy for choroidal neovascularization in age-related macular degeneration. Datseris I; Kontadakis GA; Diamanti R; Datseris I; Pallikaris IG; Theodossiadis P; Tsilimbaris MK Semin Ophthalmol; 2015 Mar; 30(2):112-7. PubMed ID: 24117412 [TBL] [Abstract][Full Text] [Related]
19. Comparison of visual outcome and regression pattern of myopic choroidal neovascularization after intravitreal bevacizumab or after photodynamic therapy. Hayashi K; Ohno-Matsui K; Teramukai S; Shimada N; Moriyama M; Hayashi W; Yoshida T; Tokoro T; Mochizuki M Am J Ophthalmol; 2009 Sep; 148(3):396-408. PubMed ID: 19427991 [TBL] [Abstract][Full Text] [Related]
20. Intravitreal anti-vascular endothelial growth factor for choroidal neovascularization in ocular histoplasmosis. Hu J; Hoang QV; Chau FY; Blair MP; Lim JI Retin Cases Brief Rep; 2014; 8(1):24-9. PubMed ID: 25372202 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]